This is a regulatory disclosure submitted to both BSE Limited and National Stock Exchange of India Limited regarding an upcoming board meeting of Rossari Biotech Limited.
The Board of Directors meeting is scheduled to be held on Saturday, July 18, 2026. The primary agenda item is to approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter ended June 30, 2026 (Q1 FY2027).
This notice is issued pursuant to Regulation 29 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The disclosure also confirms that the "Trading Window" for dealing in securities of the Company remains closed for all "Designated Persons and their immediate relatives" covered under the Company's Code of Conduct for Prevention of Insider Trading. The closure period began on July 01, 2026 and will continue until 48 hours after the announcement of the Unaudited Financial Results for the quarter ended June 30, 2026.
This intimation was previously communicated via letter dated June 25, 2026, and is available on the company's website at www.rossari.com.
The document is digitally signed by Parul Gupta, Company Secretary & Head - Legal (Membership No.: A38895).